Could a neck device shield lungs after brain trauma?

NCT ID NCT04935697

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested a non-invasive device that stimulates the vagus nerve (nVNS) in patients hospitalized with mild-to-moderate traumatic brain injury. The goal was to see if adding nVNS to standard care could prevent severe lung inflammation and the need for a breathing machine. Only 3 people took part, so the results are very preliminary.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
non-invasive vagus nerve stimulation (nVNS) device (gammaCore Sapphire S)
What this could lead to
If it works, this could point toward a way to prevent serious lung complications after a traumatic brain injury.
What could go wrong
This was a very small pilot study with only 3 participants, so results are not reliable. Larger trials are needed to know if it really helps.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LUNG INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AHN Allegheny General Hospital

    Pittsburgh, Pennsylvania, 15212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.